Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Loan Update

30 Apr 2014 12:00

RNS Number : 9054F
Fitbug Holdings PLC
30 April 2014
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

30 April 2014

Fitbug Holdings Plc ('Fitbug' or 'the Company')

Agrees extension of all loans to mid 2015 and secures additional £1 million loan on attractive terms

Legal action against Fitbit on course for court decision in 2015.

 

Fitbug Holdings Plc, the AIM listed provider of online personal health and well-being services, is pleased to announce that it has agreed that the repayment date of all loans to the Company from NW1 Investments Limited and Kifin Limited, a Kirsh Group subsidiary, be extended to 31 July 2015. Other terms remain unchanged including the interest rate which remains at 5%.

 

The Company is also pleased to announce that it has agreed a further £1 million loan ('the Loan') from NW1 Investments Limited ('Loan Holder'). The Loan is repayable by 31 July 2015 and will accrue interest at 5% per annum, payable on a quarterly basis. NW1 Investments Limited is a company in which the family of David Turner and Allan Fisher, both directors of Fitbug, have a material interest.

 

The independent directors of the Company, being Fergus Kee, Malcolm Fried, Paul Landau, Ann Jones, Geoffrey Simmonds and Andrew Brummer, consider, having consulted with Cantor Fitzgerald Europe, that the terms of the Loan are fair and reasonable in so far as shareholders are concerned.

 

The Company's legal action against Fitbit alleging trademark infringement, as well as unfair competition and unfair business practices, continues to progress and is scheduled to go to trial in the U.S. District Court for the Northern California in early 2015.

 

Fergus Kee, Chairman of Fitbug said, "This term extension on existing loans and the additional loan capital, both on attractive terms, significantly strengthens the Company's financial position at a time of strongly growing demand for wearable technology. We have an exciting pipeline of business ahead and we look forward to developing this and continuing our investment into both our sales strategy and product."

 

**ENDS**

 

For further information contact:

 

Paul Landau/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce / William Lynne

Hybridan LLP

020 7947 4350 / 020 7947 4361

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

 

 

Notes

 

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology providing users with personalised weekly activity and nutrition targets, feedback, advice and encouragement.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes fitness operators and consumers. Increasingly, Fitbug's platform acts as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. The Company's main focus is now on building strategic partnerships with organisations that can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in the UK, Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com.

 

The Fitbug business was founded by Paul Landau, CEO of Fitbug Limited. Fergus Kee, Chairman of the Company is the former Managing Director of Bupa's £2.1 billion turnover UK and North American Division.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIMMMTMBMJBFI
Date   Source Headline
17th Aug 200711:30 amRNSAIM Rule 26
19th Jul 20079:00 amRNSBUPA completes investment
11th Jul 20079:22 amRNSApplication for Listing
3rd Jul 200710:45 amRNSApplication for Listing
22nd Jun 20077:01 amRNSBUPA take 29.9% stake
11th Jun 20077:00 amRNSAgreement with Alliance Boots
5th Jun 20077:01 amRNSAgreement with Esporta
29th May 20071:03 pmRNSResult of EGM
4th May 20072:53 pmRNSNotice of EGM
25th Apr 20077:00 amRNSInterim Results
13th Apr 200712:31 pmRNSDirector/PDMR Shareholding
23rd Jan 20078:42 amRNSTotal Voting Rights
19th Jan 20072:37 pmRNSPlacing
15th Dec 20062:45 pmRNSTotal Voting Rights
14th Dec 20066:02 pmRNSResult of AGM
14th Nov 20067:02 amRNSFinal Results
26th Jul 20068:08 amRNSAcquisition
5th Jun 20067:00 amRNSAgreement with PruHealth
5th May 20069:30 amRNSContract Win
12th Apr 20064:37 pmRNSOptions Granted
10th Apr 200610:34 amRNSInterim Results
27th Feb 20067:00 amRNSDisposal of Liberation
9th Feb 20067:00 amRNSContract with Leisure Op.
16th Dec 20052:27 pmRNSAGM Statement
23rd Nov 20057:01 amRNSUS Licensing Agreement
16th Nov 20057:02 amRNSFinal Results
25th Aug 20054:42 pmRNSDirector/PDMR Shareholding
4th Aug 200512:22 pmRNSShare Price/Press Speculation
25th Jul 20057:00 amRNSDirectors Holding / Update
5th May 20054:56 pmRNSResult of EGM
18th Apr 20057:00 amRNSInterim Results
13th Apr 20057:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.